---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-21-100070"
form_type: "8-K"
ticker: "MED"
cik: "0000910329"
company_name: "MEDIFAST INC"
filed_at: "2021-08-04T23:59:59+00:00"
generated_at: "2026-06-29T22:58:25.611648+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Medifast Q2 2021 revenue $394.2M (+79% YoY), EPS $3.96; FY guidance $1.425-1.525B

## Summary
- Revenue $394.2M, up 79.2% YoY; net income $47M (+114.1%); diluted EPS $3.96 (+112.9%).
- Active OPTA VIA coaches 59,200 (+62.2%); revenue per coach $6,662 (+13.9%).
- Gross margin 74.5% vs 72.4%; operating income $61.4M, up 118.5%
- FY2021 guidance: revenue $1.425-1.525B, EPS $12.70-14.17.
- Declared $1.42/sh dividend (pay Aug 6); $12.2M share repurchases; $125M credit facility undrawn.

## SEC filing metadata
- accession: 0001104659-21-100070
- form_type: 8-K
- ticker: MED
- cik: 0000910329
- company_name: MEDIFAST INC
- filed_at: 2021-08-04T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/910329/000110465921100070/0001104659-21-100070-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/910329/000110465921100070/tm2124088d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-21-100070
- JSON: https://secwatch.observer/filing/0001104659-21-100070.json
- Plain text: https://secwatch.observer/filing/0001104659-21-100070.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.